netFormulary Northern Lincolnshire NHS
Formulary  
 Search
 Formulary Chapter 5: Infections - Full Chapter
Notes:

The Antibiotic Formulary and Prescribing Advice for Adult Patients should be read in conjunction with this chapter -  aim is to encourage the appropriate use of this valuable resource.

 

Antibiotic prescribing for primary care can be viewed via this link

Guidance on Antibiotic in Primary care

 Details...
05.03.03.02  Expand sub section  Chronic hepatitis C
Boceprevir (Victrelis®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

capsule

 
Link  MHRA Alert: Boceprevir (Victrelis) and telaprevir (Incivo): predictive factors for sepsis, worsening liver function, and mortality
Link  NICE TA253: hepatitis
   
Daclatasvir  (Daklinza®)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine
NHS England

Tablet

 
Link  NICE TA364: Daclatasvir for treating chronic hepatitis C
Link  MHRA Alert: Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone
   
Dasabuvir (Exviera®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Tablet

 
Link  NICE TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
   
Elbasvir/Grazoprevir (Zepatier®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
NHS England
 
Link  NICE TA413: Elbasvir–grazoprevir for treating chronic hepatitis C
   
Glecaprevir and Pibrentasvir (Maviret®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England
BlueTeq

Tablet

 
Link  NICE TA499: Glecaprevir–pibrentasvir for treating chronic hepatitis C
   
Ledipasvir and Sofosbuvir (Harvoni®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Tablet

 
Link  NICE TAG63: Ledipasvir–sofosbuvir for treating chronic hepatitis C
Link  MHRA Alert: Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone
Link  NICE TA430 : Sofosbuvir–velpatasvir for treating chronic hepatitis C
   
Ombitasvir/ paritaprevir/ ritonavir (Viekirax®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

tablet

 
Link  NICE TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
Link  MHRA Alert: Cobicistat, ritonavir and coadministration with a steroid: risk of systemic corticosteroid adverse effects
   
Sofosbuvir (Sovaldi®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Tablet

 
Link  NICE TA330: Sofosbuvir for treating chronic hepatitis C
Link  MHRA Alert: Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone
   
Sofosbuvir, Velpatasvir and Voxilaprevir (Vosevi®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England
BlueTeq

Tablet

 
Link  NICE TA507: Sofosbuvir–velpatasvir for treating chronic hepatitis C
   
Telaprevir (Incivo®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Tablet

 
Link  MHRA Alert: Boceprevir (Victrelis) and telaprevir (Incivo): predictive factors for sepsis, worsening liver function, and mortality
Link  NICE TA252: Telaprevir in hepatitis C
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Green -Medicines suitable for routine use within primary care and Secondary care Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies  

Amber

Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.   

Red

Red-Hospital initiation and continuation only  

Amber Shared Care Protocol

AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised  

Blue

To be supplied from the appropriate commissioned provider.   

Green 2

GREEN 2- to be prescribed by primary care only   

Grey

GREY- NON FORMULARY (As agreed by Area Prescribing Committee)  

netFormulary